Ether open interest rose over the past 30 days, signalling traders launching long positions, buyers entering the market, and ETH’s uptrend to continue.Ether open interest rose over the past 30 days, signalling traders launching long positions, buyers entering the market, and ETH’s uptrend to continue.

Ethereum Holds Firm At $2,328 As Open Interest Rises, Suggesting ETH’s Next Target Is $2,700-$3,000

For feedback or concerns regarding this content, please contact us at crypto.news@mexc.com
ethereum

Ethereum (ETH) is likely to maintain a strong trend as disclosed today by market analyst CryptoQuant. The analyst shared on-chain data showing a significant increase in futures open interest, signaling new liquidity is entering the Ethereum derivatives market.

Open Interest (OI) is an important financial indicator that shows the total number of active futures and options contracts that have not yet closed or settled, indicating how many traders still have open positions that are active. Whenever open interest rises, it often suggests that new capital is flowing into the market. On the other hand, when it declines, it shows that capital is exiting the market.

Rising Open Interest Indicates Ether’s Uptrend

Today, Ether stands at $2,328 after recording a 0.8% rise over the past 24 hours. Also, its price has been up 15.7% and 18.2% over the past week and month, respectively, driven by the open interest bullish indicator as revealed by the analyst. 

As ETH rises toward the $3,000 level, the 30-day open interest change has risen significantly, according to fresh data from CryptoQuant analysts. Over the past 30 days, a huge number of contracts not only remain open (active) but have increased massively. This shows that new contracts have been created more than the closed ones during the period, indicating that new participants are entering the Ethereum market or traders are adding new contracts to their existing positions.

CryptoQuant analysts closely examined ETH perpetual futures long/short ratios across leading crypto exchanges, including BitMEX, Kraken, Derbit, OKX, Bybit, Binance, Bitfinex, HTX Global, and Gate.io. As a result, they identified metrics that pointed out important insights into trader positioning and possible ETH market direction. The latest metrics from the above top nine largest futures platforms by open interest disclosed a remarkable sentiment outlook. The data revealed significant increases in high long ratios, suggesting traders strongly engaging in bullish positioning, a move that supports Ethereum’s continued uptrend.

ETHUSDThe current price of Ethereum is $2,314.

ETH Preparing For A Strong Breakout

Ethereum price currently consolidates at the $2,170 and $2,351 resistance range as it awaits the Fed’s decision today, Wednesday, March 18, 2026. While the Federal Reserve is anticipated to keep interest rates unchanged, traders will closely follow Fed’s chair Jerome Powell’s upcoming speech, which could redefine the prices of Bitcoin and several other altcoins.   

ETH’s price pattern displays early signs of a rebound after a persistent downtrend. Its price currently holds a crucial resistance zone that could trigger the next trend as the selling pressure around the $1,800-$1,900 range has been absorbed.

Its price is currently testing the $2,300 and $2,400 range, indicating buyers stepping into the market, and suggesting a potential breakout towards $2,776 and a possible climb towards the $3,000 level. 

Market Opportunity
Ethereum Logo
Ethereum Price(ETH)
$2,191.43
$2,191.43$2,191.43
+0.17%
USD
Ethereum (ETH) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact crypto.news@mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Michael Saylor Pushes Digital Capital Narrative At Bitcoin Treasuries Unconference

Michael Saylor Pushes Digital Capital Narrative At Bitcoin Treasuries Unconference

The post Michael Saylor Pushes Digital Capital Narrative At Bitcoin Treasuries Unconference appeared on BitcoinEthereumNews.com. The suitcoiners are in town.  From a low-key, circular podium in the middle of a lavish New York City event hall, Strategy executive chairman Michael Saylor took the mic and opened the Bitcoin Treasuries Unconference event. He joked awkwardly about the orange ties, dresses, caps and other merch to the (mostly male) audience of who’s-who in the bitcoin treasury company world.  Once he got onto the regular beat, it was much of the same: calm and relaxed, speaking freely and with confidence, his keynote was heavy on the metaphors and larger historical stories. Treasury companies are like Rockefeller’s Standard Oil in its early years, Michael Saylor said: We’ve just discovered crude oil and now we’re making sense of the myriad ways in which we can use it — the automobile revolution and jet fuel is still well ahead of us.  Established, trillion-dollar companies not using AI because of “security concerns” make them slow and stupid — just like companies and individuals rejecting digital assets now make them poor and weak.  “I’d like to think that we understood our business five years ago; we didn’t.”  We went from a defensive investment into bitcoin, Saylor said, to opportunistic, to strategic, and finally transformational; “only then did we realize that we were different.” Michael Saylor: You Come Into My Financial History House?! Jokes aside, Michael Saylor is very welcome to the warm waters of our financial past. He acquitted himself honorably by invoking the British Consol — though mispronouncing it, and misdating it to the 1780s; Pelham’s consolidation of debts happened in the 1750s and perpetual government debt existed well before then — and comparing it to the gold standard and the future of bitcoin. He’s right that Strategy’s STRC product in many ways imitates the consols; irredeemable, perpetual debt, issued at par, with…
Share
BitcoinEthereumNews2025/09/18 02:12
Trump White House Registers Aliens.gov—Is the UFO File Drop Imminent?

Trump White House Registers Aliens.gov—Is the UFO File Drop Imminent?

The post Trump White House Registers Aliens.gov—Is the UFO File Drop Imminent? appeared on BitcoinEthereumNews.com. In brief The White House registered aliens.gov
Share
BitcoinEthereumNews2026/03/19 05:33
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26